Industry

Rally at Doug Ford’s office: Health care workers to protest on Monday morning as staffing cuts take toll on workers, patients

More than 9,000 nurses and PSW jobs could be lost by 2027-28 if government does not increase funding TORONTO–(BUSINESS WIRE)–Health care workers represented by the Canadian Union of Public Employees will hold a rally outside local Premier Doug Ford’s office in Etobicoke in response to funding cuts by the provincial government. The government’s fall economic … [Read more…]

Matter Health Appoints Sarah Chouinard, MD, as Chief Medical Officer

NASHVILLE, Tenn.–(BUSINESS WIRE)–Matter Health, a medical group delivering on-site care inside senior-restricted affordable housing communities, today announced the appointment of Sarah Chouinard, MD, as Chief Medical Officer. In this role, Dr. Chouinard will oversee all aspects of clinical delivery and model performance, including quality outcomes, clinical programs, risk management, and overall model performance across Matter … [Read more…]

Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction

Divestiture streamlines operations and advances the Company’s strategy to fully exit non-core activities LOS ANGELES–(BUSINESS WIRE)–$NAGE #Biotech—Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces the sale of its ChromaDex Reference Standards business to LGC, as of February 24, 2026, … [Read more…]

Vir Biotechnology Announces Pricing of Public Offering of Common Stock

SAN FRANCISCO–(BUSINESS WIRE)–Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer, today announced the pricing of its underwritten public offering of 17,647,058 shares of its common stock at a price to the public of $8.50 … [Read more…]

U.S. Physical Therapy Reports Fourth Quarter and Full Year 2025 Results

HOUSTON–(BUSINESS WIRE)–U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the fourth quarter and full year ended December 31, 2025. FINANCIAL HIGHLIGHTS Year Ended December 31, 2025 versus Year Ended December 31, 2024 … [Read more…]

STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction

LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that more than 4 million Implantable Collamer® Lenses (ICLs) have been sold worldwide, marking a milestone in the global shift away from laser-based refractive surgery. This … [Read more…]

Inspira Health Enhances Leadership Model to Strengthen “Systemness”

This evolution formalizes shared decision-making and collaboration to support patients accessing faster, more coordinated care, close to home MULLICA HILL, N.J.–(BUSINESS WIRE)–Inspira Health announced an enhanced shared decision-making structure designed to further strengthen “systemness” across the organization. Through smaller, cross-functional teams, the new leadership structure will provide additional opportunities for leaders to share learnings, align … [Read more…]

Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty

New patient-specific solution expands Catalyst’s portfolio, enabling precise translation of 3D surgical plans into the operating room to reduce steps and increase accuracy NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Archer® Patient-Specific … [Read more…]

Charles River Laboratories Provides Update on Planned Divestitures

– Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets – – Updates 2026 Financial Guidance – WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as the … [Read more…]

Ascensia Diabetes Care Appoints Peter Bodlund as President and Chief Executive Officer

BASEL, Switzerland–(BUSINESS WIRE)–#ascensia–Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced the appointment of Peter Bodlund as President and Chief Executive Officer, effective April 1, 2026. He succeeds Koichiro Sato, who will continue in his roles as Chief Operating Officer of PHC Group and Head of … [Read more…]